Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Mesh:Chi-Square Distribution"" wg kryterium: Temat


Tytuł :
Is reperfusion useful in ischaemic stroke patients presenting with a low national institutes of health stroke scale and a proximal large vessel occlusion of the anterior circulation?
Autorzy :
Dargazanli, Cyril
Consoli, Arturo
Gory, Benjamin
Blanc, Raphael
Labreuche, Julien
Preda, Cristian
Bourdain, Frédéric
Decroix, Jean-Pierre
Redjem, Hocine
Ciccio, Gabriele
Mazighi, Mikael
Smajda, Stanislas
Desilles, Jean-Philippe
Riva, Roberto
Labeyrie, Paul-Emile
Coskun, Oguzhan
Rodesch, Georges
Turjman, Francis
Piotin, Michel
Lapergue, Bertrand
Pokaż więcej
Temat :
Sciences du Vivant [q-bio]
Mechanical thrombectomy
Cerebrovascular procedures
Cerebrovascular disease/stroke
Recanalization
Clinical studies
Reperfusion
Revascularization
Mild stroke
Minor stroke
Ischaemic stroke
Mesh:Infarction
Mesh:Middle Cerebral Artery/physiopathology
Mesh:Middle Cerebral Artery/mortality
Mesh:Middle Cerebral Artery/diagnostic imaging
Mesh:Humans
Mesh:France
Mesh:Female
Mesh:Endovascular Procedures*/mortality
Mesh:Endovascular Procedures*/adverse effects
Mesh:Disability Evaluation
Mesh:Chi-Square Distribution
Mesh:Cerebrovascular Circulation
Mesh:Carotid Stenosis/therapy
Mesh:Carotid Stenosis/physiopathology
Mesh:Carotid Stenosis/mortality
Mesh:Carotid Stenosis/diagnostic imaging
Mesh:Carotid Artery
Mesh:Internal/physiopathology
Mesh:Internal/diagnostic imaging
Mesh:Aged
Mesh:80 and over
Mesh:Risk Factors
Mesh:Adult
Mesh:Treatment Outcome
Mesh:Time Factors
Mesh:Thrombectomy*/mortality
Mesh:Thrombectomy*/adverse effects
Mesh:Retrospective Studies
Mesh:Reperfusion/mortality
Mesh:Reperfusion/methods
Mesh:Reperfusion/adverse effects
Mesh:Registries
Mesh:Recovery of Function
Mesh:Odds Ratio
Mesh:Middle Aged
Mesh:Male
Mesh:Logistic Models
Mesh:Middle Cerebral Artery/therapy
Tytuł :
Polymorphisme génétique du cytochrome P450 2E1 et le risque du cancer du nasopharynx
Autorzy :
Ben Chaaben, Arij
Abaza, Hajer
Douik, Hayet
Chaouch, Leila
Ayari, Fayza
Ouni, Nesrine
Mamoghli, Tasnim
Mejri, Rachida
Harzallah, Latifa
Guemira, Fethi
Ben Guezella, Dorra
Pokaż więcej
Temat :
MESH: Alleles
MESH: Odds Ratio
Polymorphisme génétique
MESH : Risk
MESH: Male
Cytochrome P450 2E1
Carcinome du nasopharynx
MESH: Risk
[ SDV.CAN ] Life Sciences [q-bio]/Cancer
MESH: Polymorphism, Genetic
MESH : Alleles
MESH : Polymorphism, Restriction Fragment Length
MESH : Case-Control Studies
MESH: Tunisia
MESH : Odds Ratio
MESH : Male
MESH: Genotype
MESH : Tunisia
MESH : Gene-Environment Interaction
Détoxication
[SDV.CAN]Life Sciences [q-bio]/Cancer
Detoxication
MESH: Nasopharyngeal Neoplasms
MESH: Polymorphism, Restriction Fragment Length
MESH : Female
MESH: Female
MESH: Adult
MESH: Mutation
MESH : Genotype
[ SDV ] Life Sciences [q-bio]
Nasopharyngeal carcinoma
MESH: Gene-Environment Interaction
MESH: Humans
MESH : Nasopharyngeal Neoplasms
MESH: Cytochrome P-450 CYP2E1
MESH: Case-Control Studies
MESH: Chi-Square Distribution
MESH : Mutation
MESH : Chi-Square Distribution
MESH : Adult
MESH : Humans
[SDV]Life Sciences [q-bio]
Genetic polymorphism
MESH : Polymorphism, Genetic
MESH : Cytochrome P-450 CYP2E1
Źródło :
Bulletin du Cancer, John Libbey Eurotext, 2015, 102 (12), pp.967-972. 〈10.1016/j.bulcan.2015.09.013〉
Bulletin du Cancer, John Libbey Eurotext, 2015, 102 (12), pp.967-972. ⟨10.1016/j.bulcan.2015.09.013⟩
Tytuł :
Impact of Thymoglobulin by Stem Cell Source (Peripheral Blood Stem Cell or Bone Marrow) After Myeloablative Stem Cell Transplantation From HLA 10/10-Matched Unrelated Donors: A Report From the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire
Autorzy :
Ravinet, Aurelie
Cabrespine, Aurelie
Socie, Gerard
Milpied, Noel
Yakoub Agha, Ibrahim
Nguyen, Stephanie
Michallet, Mauricette
Menard, Anne-Lise
Maillard, Natacha
Mohty, Mohamad
Suarez, Felipe
Huynh, Anne
Marchand, Tony
Deteix, Clemence
Cassuto Jill, Patrice
Maury, Sebastien
Chevallier, Patrice
Oumedaly, Reman
Peffault De Latour, Regis
Bay, Jacques-Olivier
Pokaż więcej
Temat :
Mesh:Middle Aged
Mesh:HLA Antigens/immunology
Mesh:Transplantation Conditioning/adverse effects
Mesh:Disease-Free Survival
Mesh:Myelodysplastic Syndromes/diagnosis
Mesh:Graft vs Host Disease/prevention & control
Mesh:Proportional Hazards Models
Mesh:Chi-Square Distribution
Mesh:Peripheral Blood Stem Cell Transplantation*/methods
Sciences du Vivant [q-bio]
Mesh:Histocompatibility Testing
Mesh:Treatment Outcome
Mesh:Immunosuppressive Agents/therapeutic use
Mesh:Chronic Disease
Mesh:Recurrence
Mesh:Cyclophosphamide/therapeutic use
Mesh:Myelodysplastic Syndromes/mortality
Mesh:Adult
Mesh:Antilymphocyte Serum/adverse effects
Mesh:Young Adult
Mesh:Dose Fractionation
Mesh:Immunosuppressive Agents/adverse effects
Mesh:Myelodysplastic Syndromes/surgery
Mesh:Bone Marrow Transplantation*/methods
Mesh:Adolescent
Mesh:Busulfan/therapeutic use
Mesh:Myeloablative Agonists/therapeutic use
Mesh:Whole-Body Irradiation
Mesh:Antilymphocyte Serum/therapeutic use
Mesh:Male
Mesh:Bone Marrow Transplantation*/mortality
Mesh:Peripheral Blood Stem Cell Transplantation*/adverse effects
Mesh:Time Factors
Mesh:Humans
Mesh:Acute/immunology
Mesh:Transplantation Conditioning/methods
Mesh:Kaplan-Meier Estimate
Mesh:Acute/diagnosis
Mesh:Acute/mortality
Mesh:Acute/surgery
Mesh:Risk Factors
Mesh:Graft vs Host Disease/immunology
Mesh:Female
Mesh:France
Mesh:Retrospective Studies
Mesh:Unrelated Donors
Mesh:Myelodysplastic Syndromes/immunology
Mesh:Myeloid
Mesh:Histocompatibility
Mesh:Peripheral Blood Stem Cell Transplantation*/mortality
Mesh:Multivariate Analysis
Mesh:Leukemia
Mesh:Transplantation Conditioning/mortality

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies